Q2 2020 13F Holders as of 30 Jun 2020
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
58,874,321
-
Number of holders
-
159
-
Total 13F shares, excl. options
-
55,140,491
-
Shares change
-
+1,346,480
-
Total reported value, excl. options
-
$630,777,920
-
Value change
-
+$15,624,266
-
Put/Call ratio
-
626%
-
Number of buys
-
82
-
Number of sells
-
-68
-
Price
-
$11.44
Significant Holders of Vanda Pharmaceuticals Inc. - Common Stock, par value $0.001 per share (VNDA) as of Q2 2020
183 filings reported holding VNDA - Vanda Pharmaceuticals Inc. - Common Stock, par value $0.001 per share as of Q2 2020.
Vanda Pharmaceuticals Inc. - Common Stock, par value $0.001 per share (VNDA) has 159 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 55,140,491 shares
of 58,874,321 outstanding shares and own 94% of the company stock.
Largest 10 shareholders include BlackRock Inc. (9,429,230 shares), ARMISTICE CAPITAL, LLC (4,800,000 shares), VANGUARD GROUP INC (4,303,657 shares), RENAISSANCE TECHNOLOGIES LLC (4,229,822 shares), Palo Alto Investors LP (4,116,548 shares), STATE STREET CORP (3,678,612 shares), MACQUARIE GROUP LTD (3,290,578 shares), Invesco Ltd. (1,807,790 shares), DIMENSIONAL FUND ADVISORS LP (1,433,008 shares), and PRUDENTIAL FINANCIAL INC (1,350,613 shares).
This table shows the top 159 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.